BlackDiamond Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Sell
961
-31
-3% -$10.6K 0.16% 133
2026
Q1
$349K Buy
992
+56
+6% +$20K 0.17% 122
2025
Q4
$352K Sell
936
-38
-4% -$12.1K 0.17% 122
2025
Q3
$275K Buy
974
+79
+9% +$22.9K 0.15% 130
2025
Q2
$260K Buy
895
+71
+9% +$20.1K 0.15% 129
2025
Q1
$219K Buy
824
+29
+4% +$8.56K 0.15% 140
2024
Q4
$207K Sell
795
-94
-11% -$27.9K 0.12% 154
2024
Q3
$266K Buy
889
+232
+35% +$75.9K 0.16% 135
2024
Q2
$213K Buy
+657
New +$193K 0.14% 140

Other funds holding AMGN

BlackDiamond Wealth Management's AMGN Position: Q2 2026 in Review

BlackDiamond Wealth Management reduced its Amgen (AMGN) stake by 3.1% in Q2 2026, selling an estimated $10.6K and leaving 961 shares worth $401K. The position accounts for 0.16% of the portfolio, ranked #133.

BlackDiamond Wealth Management first reported a position in AMGN in Q2 2024 and has held it in 9 quarters since. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • BlackDiamond Wealth Management held 961 shares of Amgen worth $401K as of Q2 2026.
  • BlackDiamond Wealth Management sold 31 Amgen shares in Q2 2026, an estimated $10.6K.
  • Amgen made up 0.16% of BlackDiamond Wealth Management's portfolio in Q2 2026, its #133 holding.
  • BlackDiamond Wealth Management first reported a position in Amgen in Q2 2024 and has held it in 9 quarters since.
  • 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on BlackDiamond Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.